Why WeightWatchers Wants in on Drugs Like Ozempic

T

The Journal.

Guest
WeightWatchers is buying digital health company Sequence to capitalize on the hot market for diabetes and weight loss drugs including Ozempic and Wegovy. WSJ's Andrea Petersen explains what this could mean for the wellness industry.



Further Reading:

-WeightWatchers Moves Into the Ozempic Market With Telehealth Deal

-How a Diabetes Drug Became the Talk of Hollywood, Tech and the Hamptons

-Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight


Learn more about your ad choices. Visit megaphone.fm/adchoices

Continue reading...
 
You must log in or register to reply here.

Similar threads

T
Trillion Dollar Shot, Episode 1: Birth of a Blockbuster
Replies
0
Views
23
The Journal.
T
T
The Ozempic Era of Weight Loss
Replies
0
Views
21
The New York Times
T
T
Ozempic Expert: Ozempic Increases This Disease By A Factor Of 9! They're Lying To You About Ozempic Side Effects & What It's Doing To Our Brains! - Jo
Replies
0
Views
45
The Diary Of A CEO with Steven Bartlett
T
O
Johann Hari: Uncovering if Ozempic is a Miracle Drug or Health Hazard & 3 Things They Do Not Want To Tell About Ozempic
Replies
0
Views
40
On Purpose with Jay Shetty
O
T
The Ozempic Expert: Ozempic Transforms Your Gut Microbiome! People Are Being Overdosed On Ozempic! Microdosing Saved My Life! - Dr Tyna Moore
Replies
0
Views
49
The Diary Of A CEO with Steven Bartlett
T
Back
Top